These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38006675)

  • 21. Generation of two induced pluripotent stem cell lines (RCMGi005-A/B) from human skin fibroblasts of a cystic fibrosis patient with homozygous F508del mutation in CFTR gene.
    Panchuk I; Kondrateva E; Demchenko A; Grigorieva O; Erofeeva A; Amelina E; Tabakov V; Orlova M; Voronina E; Pozhitnova V; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2022 Oct; 64():102896. PubMed ID: 36067639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview.
    Sundaravadivelu PK; Raina K; Thool M; Ray A; Joshi JM; Kaveeshwar V; Sudhagar S; Lenka N; Thummer RP
    Adv Exp Med Biol; 2022; 1376():151-180. PubMed ID: 34611861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
    Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
    Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
    Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
    Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female.
    Nimonkar MM; Arunachal G; Dash SS; Kandy SK; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
    Stem Cell Res; 2023 Aug; 70():103130. PubMed ID: 37269666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A.
    Zhang Y; Li A; Huang CL; Wang G; Wang D
    Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of canine induced pluripotent stem cells under feeder-free conditions using Sendai virus vector encoding six canine reprogramming factors.
    Tsukamoto M; Kimura K; Yoshida T; Tanaka M; Kuwamura M; Ayabe T; Ishihara G; Watanabe K; Okada M; Iijima M; Nakanishi M; Akutsu H; Sugiura K; Hatoya S
    Stem Cell Reports; 2024 Jan; 19(1):141-157. PubMed ID: 38134923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation of iPSC line (RCMGi002-A) from dermal fibroblasts of a cystic fibrosis female patient with homozygous F508del mutation.
    Kondrateva E; Demchenko A; Slesarenko Y; Yasinovsky M; Amelina E; Tabakov V; Voronina E; Lavrov A; Smirnikhina S
    Stem Cell Res; 2021 May; 53():102251. PubMed ID: 33684631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of chimpanzee induced pluripotent stem cell lines for cross-species comparisons.
    Imamura M; Nakai R; Ohnuki M; Hamazaki Y; Tanabe H; Sato M; Harishima Y; Horikawa M; Watanabe M; Oota H; Nakagawa M; Suzuki S; Enard W
    In Vitro Cell Dev Biol Anim; 2024 May; 60(5):544-554. PubMed ID: 38386235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.
    Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S
    Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a Vietnamese ethnicity induced pluripotent stem cell line (VRISGi001-A) from umbilical cord blood hematopoietic stem cells under a feeder-free system.
    Tran TT; Nguyen TH; Nguyen TT; Nguyen XH
    Stem Cell Res; 2021 May; 53():102345. PubMed ID: 33878709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of induced pluripotent stem cell line (ZZUi030-A) from a patient with spastic paraplegia type 7.
    Zhang Q; Wang Z; Sun H; Chen N; Xu X; Yang J; Gao Y; Wang Y; Xu Y
    Stem Cell Res; 2021 Oct; 56():102525. PubMed ID: 34509920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of an induced pluripotent stem cell line (CSUi003-A) from fibroblasts of a healthy elderly individual.
    Zhao H; Wang L; Wu J; Ren J; Chen Q; Luo H; Zuo X; Tang Y
    Stem Cell Res; 2021 May; 53():102326. PubMed ID: 33845242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells.
    Gao Y; Cheng Y; Wen J; Xiao D; Xu J; Cai C; Hu J
    Stem Cell Res; 2023 Jun; 69():103088. PubMed ID: 37099933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer.
    Ai D; Yang X; Li X; Liu N; Xie X; Liu Y; Song W
    Stem Cell Res; 2023 Jun; 69():103096. PubMed ID: 37104933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C).
    Yang M; Liu M; Vajda A; O'Brien T; Henshall D; Hardiman O; Shen S
    Stem Cell Res; 2019 Oct; 40():101558. PubMed ID: 31514057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.